The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus

被引:253
作者
Hedestam, Gunilla B. Karlsson [2 ,3 ]
Fouchier, Ron A. M. [4 ,5 ]
Phogat, Sanjay [1 ]
Burton, Dennis R. [6 ,7 ]
Sodroski, Joseph [8 ]
Wyatt, Richard T. [1 ]
机构
[1] NIAID, NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA
[2] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm 17177, Sweden
[3] Swedish Inst Infect Dis Control, Solna 17182, Sweden
[4] Erasmus MC, Natl Influenza Ctr, NL-3015GE Rotterdam, Netherlands
[5] Erasmus MC, Dept Virol, NL-3015GE Rotterdam, Netherlands
[6] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[7] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[8] Harvard Univ, Sch Med, Div AIDS, Dana Farber Canc Inst,Dept Cancer Immunol & AIDS, Boston, MA 02115 USA
关键词
GP120 ENVELOPE GLYCOPROTEIN; HUMAN MONOCLONAL-ANTIBODY; PROTECTIVE IMMUNITY; RECEPTOR-BINDING; A VIRUS; REVERSE-GENETICS; PROTEOLYTIC CLEAVAGE; GLYCOSYLATION SITES; VACCINE DEVELOPMENT; CD4-BOUND STATE;
D O I
10.1038/nrmicro1819
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability to elicit broadly neutralizing antibody responses against HIV-1 is a crucial goal for a prophylactic HIV-1 vaccine. Here, we discuss the difficulties of achieving broad HIV-1 neutralization in the context of both the effective annual human influenza virus vaccine and the need to develop a pandemic influenza vaccine. Immunogen-design strategies are underway to target functionally conserved regions of the HIV-1 envelope glycoproteins, and similar strategies might be applicable to pandemic influenza virus vaccine development. Efforts to develop broadly neutralizing vaccines against either HIV-1 or influenza virus might establish a paradigm for future vaccines against highly variable pathogens.
引用
收藏
页码:143 / 155
页数:13
相关论文
共 134 条
[1]   Intranasal, cold-adapted, live, attenuated influenza vaccine [J].
Abramson, JS .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (12) :1103-1104
[2]  
Albrecht H, 2003, AIDS Clin Care, V15, P42
[3]   CARBOHYDRATE DRAMATICALLY INFLUENCES IMMUNE REACTIVITY OF ANTISERA TO VIRAL GLYCOPROTEIN ANTIGENS [J].
ALEXANDER, S ;
ELDER, JH .
SCIENCE, 1984, 226 (4680) :1328-1330
[4]   An antibody that prevents the hemagglutinin low pH fusogenic transition [J].
Barbey-Martin, C ;
Gigant, B ;
Bizebard, T ;
Calder, LJ ;
Wharton, SA ;
Skehel, JJ ;
Knossow, M .
VIROLOGY, 2002, 294 (01) :70-74
[5]   Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis [J].
Beyer, WEP ;
Palache, AM ;
de Jong, JC ;
Osterhaus, ADME .
VACCINE, 2002, 20 (9-10) :1340-1353
[6]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[7]   STRUCTURE OF INFLUENZA-VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY [J].
BIZEBARD, T ;
GIGANT, B ;
RIGOLET, P ;
RASMUSSEN, B ;
DIAT, O ;
BOSECKE, P ;
WHARTON, SA ;
SKEHEL, JJ ;
KNOSSOW, M .
NATURE, 1995, 376 (6535) :92-94
[8]   Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody [J].
Brunel, FM ;
Zwick, MB ;
Cardoso, RMF ;
Nelson, JD ;
Wilson, IA ;
Burton, DR ;
Dawson, PE .
JOURNAL OF VIROLOGY, 2006, 80 (04) :1680-1687
[9]   Antibody vs. HIV in a clash of evolutionary titans [J].
Burton, DR ;
Stanfield, RL ;
Wilson, IA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (42) :14943-14948
[10]   EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].
BURTON, DR ;
PYATI, J ;
KODURI, R ;
SHARP, SJ ;
THORNTON, GB ;
PARREN, PWHI ;
SAWYER, LSW ;
HENDRY, RM ;
DUNLOP, N ;
NARA, PL ;
LAMACCHIA, M ;
GARRATTY, E ;
STIEHM, ER ;
BRYSON, YJ ;
CAO, YZ ;
MOORE, JP ;
HO, DD ;
BARBAS, CF .
SCIENCE, 1994, 266 (5187) :1024-1027